OGDHL Expression as a Prognostic Biomarker for Liver Cancer Patients

BACKGROUND AND OBJECTIVE: Liver cancer is a highly malignant tumor, and patients typically have poor prognoses. Metabolic reprogramming is a hallmark of cancer, and downregulation of oxoglutarate dehydrogenase-like (OGDHL) contributes to the onset and progression of several cancers. We examined the...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiao, Yan, Li, Yanqing, Fu, Zhuo, Hou, Lin, Chen, Qingmin, Cai, Yujie, Jiang, Peiqiang, He, Miao, Yang, Zhaoying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6855184/
https://www.ncbi.nlm.nih.gov/pubmed/31781311
http://dx.doi.org/10.1155/2019/9037131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6855184/
https://www.ncbi.nlm.nih.gov/pubmed/31781311
http://dx.doi.org/10.1155/2019/9037131

Ejemplares similares